China Pharma Holdings (CPHI) Receivables - Net (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Receivables - Net came in at $196262.0 in Q1 2026, down 40.33% YoY from $328901.0 in Q1 2025, and down 22.86% on a QoQ basis from $254435.0 in Q4 2025.
China Pharma Holdings (CPHI) Receivables - Net (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Receivables - Net data on file, last reported at $196262.0 in Q1 2026.
- Quarterly Receivables - Net fell 40.33% year-over-year to $196262.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $196262.0 (down 40.33% YoY) and the FY2025 annual result came in at $254435.0, down 98.16% from the prior year.
- Receivables - Net eased to $196262.0 in Q1 2026, from $254435.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $14.3 million in Q4 2023 to a low of $39019.0 in Q1 2022.
- A 5-year average of $3.5 million and a median of $254435.0 in 2025 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2024 — Receivables - Net jumped 13063.85% — and 2025, when it slumped 98.43%.
- Tracing CPHI's Receivables - Net over 5 years: stood at $421531.0 in 2022, then surged by 3290.15% to $14.3 million in 2023, then plunged by 98.38% to $232140.0 in 2024, then grew by 9.6% to $254435.0 in 2025, then retreated by 22.86% to $196262.0 in 2026.
- The last three Receivables - Net figures came in at $196262.0 (Q1 2026), $254435.0 (Q4 2025), and $224638.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 196,262.00 |
| Mar 31, 2026 | 196,262.00 |
| Dec 31, 2025 | 254,435.00 |
| Dec 31, 2025 | 254,435.00 |
| Sep 30, 2025 | 224,638.00 |
| Sep 30, 2025 | 224,638.00 |
| Jun 30, 2025 | 13.91 Mn |
| Jun 30, 2025 | 13.91 Mn |
| Mar 31, 2025 | 328,901.00 |
| Mar 31, 2025 | 328,901.00 |
| Dec 31, 2024 | 232,140.00 |
| Dec 31, 2024 | 232,140.00 |
| Sep 30, 2024 | 14.27 Mn |
| Sep 30, 2024 | 14.27 Mn |
| Jun 30, 2024 | 254,850.00 |
| Jun 30, 2024 | 254,850.00 |
| Mar 31, 2024 | 14.12 Mn |
| Mar 31, 2024 | 14.12 Mn |
| Dec 31, 2023 | 14.29 Mn |
| Dec 31, 2023 | 14.29 Mn |